Healthcare - Sector
EBS is currently covered by 3 analysts with an average price target of $11. This is a potential upside of $5.95 (117.82%) from yesterday's end of day stock price of $5.05.
Emergent Biosolutions's activity chart (see below) currently has 127 price targets and 105 ratings on display. The stock rating distribution of EBS is 88.89% BUY and 11.11% SELL.
Analysts' price targets on this stock were met 66.86% of the time, taking 98.64 days on average.
Highest price target for EBS is $12, Lowest price target is $10, average price target is $11.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 09-Sep-2026. First documented stock forecast 27-Sep-2017.
Currently out of the existing stock ratings of EBS, 8 are a BUY (88.89%), 1 are a SELL (11.11%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Dec-2024
$10
$4.95 (98.02%)
$10
2 months 13 days ago
(09-Sep-2026)
0/17 (0%)
$4.32 (76.06%)
Sell Since 20-Nov-2023
3 months 1 days ago
(21-Aug-2026)
2/3 (66.67%)
$0.88 (10.84%)
7
Buy Since 11-Apr-2024
$12
$6.95 (137.62%)
$12
5 months 20 days ago
(02-Jun-2026)
7/14 (50%)
$3.79 (46.16%)
72
Buy Since 13-Sep-2024
$16
$23
2 years 2 months 9 days ago
(13-Sep-2024)
11/16 (68.75%)
$8.13 (103.30%)
123
Hold Since 12-Sep-2022
$15
$29
3 years 6 months 3 days ago
(19-May-2023)
4/8 (50%)
$6.83 (83.60%)
86
What is EBS (Emergent Biosolutions) average time for price targets to be met?
Which analyst most recently updated their price target on EBS (Emergent Biosolutions)?
Which analyst has the most public recommendations on EBS (Emergent Biosolutions)?
Which analyst is the currently most bullish on EBS (Emergent Biosolutions)?
Which analyst is the currently most reserved on EBS (Emergent Biosolutions)?